TREM and TREM-like receptors in inflammation and disease
- PMID: 19230638
- PMCID: PMC2723941
- DOI: 10.1016/j.coi.2009.01.009
TREM and TREM-like receptors in inflammation and disease
Abstract
Since the discovery of triggering receptor expressed on myeloid cells (TREM)-1 in 2000, evidence documenting the profound ability of the TREM and TREM-like receptors to regulate inflammation has rapidly accumulated. Monocytes, macrophages, myeloid dendritic cells, plasmacytoid dendritic cells, neutrophils, microglia, osteoclasts, and platelets all express at least one member of the TREM family, underscoring the importance of these proteins in the regulation of innate resistance. Recent work on the TREM family includes: characterization of a new receptor expressed on plasmacytoid dendritic cells; definition of a key role for TREM in inflammatory bowel disease and multiple sclerosis; an expanded list of diseases associated with the release of soluble forms of TREM proteins; and identification of the first well characterized TREM ligand: B7-H3, a ligand for TREM-like Transcript (TLT)-2. Moreover, analysis of TREM signaling has now identified key regulatory components and defined pathways that may be responsible for the complex functional interactions between the TREM and toll-like receptors. In addition, there is expanding evidence of a role for TREM in the regulation of integrin function via Plexin-A1. Together these new findings define the TREM and TREM-like receptors as pluripotent modifiers of disease through the integration of inflammatory signals with those associated with leukocyte adhesion.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/2723941/880f72c471a7/nihms-113971-f0001.gif)
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/2723941/cab9f65a77bb/nihms-113971-f0002.gif)
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0be3/2723941/0911a524bf0c/nihms-113971-f0003.gif)
Comment in
-
Innate resistance and inflammation.Curr Opin Immunol. 2009 Feb;21(1):1-2. doi: 10.1016/j.coi.2009.02.001. Epub 2009 Feb 14. Curr Opin Immunol. 2009. PMID: 19223161 No abstract available.
Similar articles
-
Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases.Expert Rev Clin Immunol. 2014 Feb;10(2):243-56. doi: 10.1586/1744666X.2014.866519. Epub 2013 Dec 10. Expert Rev Clin Immunol. 2014. PMID: 24325404 Review.
-
The TREM receptor family and signal integration.Nat Immunol. 2006 Dec;7(12):1266-73. doi: 10.1038/ni1411. Nat Immunol. 2006. PMID: 17110943 Review.
-
TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses.Infect Immun. 2011 Jul;79(7):2709-16. doi: 10.1128/IAI.00144-11. Epub 2011 May 9. Infect Immun. 2011. PMID: 21555403 Free PMC article.
-
Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells.J Immunol. 2007 Feb 15;178(4):1991-9. doi: 10.4049/jimmunol.178.4.1991. J Immunol. 2007. PMID: 17277102
-
Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.J Immunol. 2004 Apr 15;172(8):4956-63. doi: 10.4049/jimmunol.172.8.4956. J Immunol. 2004. PMID: 15067076
Cited by
-
TLT2 Suppresses Th1 Response by Promoting IL-6 Production in Monocyte Through JAK/STAT3 Signal Pathway in Tuberculosis.Front Immunol. 2020 Sep 11;11:2031. doi: 10.3389/fimmu.2020.02031. eCollection 2020. Front Immunol. 2020. PMID: 33042115 Free PMC article.
-
TREM-1 and pentraxin-3 plasma levels and their association with obstructive sleep apnea, obesity, and endothelial function in children.Sleep. 2013 Jun 1;36(6):923-31. doi: 10.5665/sleep.2726. Sleep. 2013. PMID: 23729936 Free PMC article.
-
TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation.Nat Commun. 2021 Apr 16;12(1):2299. doi: 10.1038/s41467-021-22620-3. Nat Commun. 2021. PMID: 33863908 Free PMC article.
-
Comparison between Symptomatic and Asymptomatic Mice after Clostridioides difficile Infection Reveals Novel Inflammatory Pathways and Contributing Microbiota.Microorganisms. 2022 Nov 30;10(12):2380. doi: 10.3390/microorganisms10122380. Microorganisms. 2022. PMID: 36557633 Free PMC article.
-
Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease.Neuropsychiatr Dis Treat. 2018 Nov 22;14:3219-3229. doi: 10.2147/NDT.S178435. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 30538480 Free PMC article.
References
-
- Sharif O, Knapp S. From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology. 2008;213:701–713. - PubMed
-
- Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Bene MC, Faure GC, Levy B. Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med. 2005;31:594–597. - PubMed
-
- Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410:1103–1107. - PubMed
-
- Gibot S, Massin F, Marcou M, Taylor V, Stidwill R, Wilson P, Singer M, Bellingan G. TREM-1 promotes survival during septic shock in mice. Eur J Immunol. 2007;37:456–466. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials